Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

This file includes redefinitions of the core modules to work with attachment, and functional forms of those modules that produce paths. You can create regular polygons with optional rounded corners ...

A public spat reportedly erupted between TMC MPs Kalyan Banerjee and Kirti Azad at the Election Commission, allegedly triggered by a memorandum submission disagreement. BJP IT cell chief Amit ...